- 01dorsaVi signs first French deal with LuxingSport.
- 02Targets sport, physio and research; sales start Nov-Dec.
- 03Enables lean European and Asian expansion.
dorsaVi Limited (ASX: DVL) has signed its first French distribution agreement, opening a new route to overseas customers for its movement-analysis technology without the expense of building a local sales team.
France-based LuxingSport will introduce the Australian technology developer’s products to professional sporting organisations, physiotherapists, and research groups through its existing sales network.
The deal marks the first step in a wider distributor-led expansion across Europe and Asia, with dorsaVi to continue selling directly to customers in Australia and the US.
Initial French sales activity is expected to start in November and December, after which the partners plan a broader market-development campaign during 2027.
French Partner with Reach
Headed by Laurent Massias, LuxingSport already works with the kinds of specialist customers dorsaVi wants to reach.
Massias approached the business several months ago after examining its range of wearable sensors and software used to measure and assess human movement.
Those products have been deployed in elite sport, clinical treatment, and workplace settings, giving dorsaVi an established platform to take into new territories.
The company’s technology has previously been used by organisations including Boeing, Caterpillar, and Medtronic, as well as by professional sporting bodies, existing relationships that are unrelated to the French agreement.
Lite International Expansion
Rather than recruiting and managing a separate salesforce in France, dorsaVi will draw on LuxingSport’s customer relationships and local market knowledge, leaving the company free to concentrate more of its resources on product development, training, and technical support as distributors seek customers on the ground.
“Rather than building large sales teams in every new jurisdiction, we see an opportunity to work with capable distributors who understand their customers and already have established routes to market,” group chief executive officer Mathew Regan said.
“LuxingSport is an encouraging first partner for this approach—its experience in elite sport, physiotherapy, and research aligns well with the customers and applications for which dorsaVi’s products have been developed.”
dorsaVi is looking beyond France to other European countries, Japan, and selected Asian markets where medical technology, rehabilitation, and sports-performance businesses have established distribution networks.
Any additional territories will be considered against customer demand, regulatory requirements, and the capabilities and commercial terms offered by prospective partners.
Flexible Sales Agreement
The French arrangement is non-exclusive and runs initially for 12 months, with automatic annual renewals unless either party provides 90 days’ notice.
LuxingSport will buy dorsaVi products and subscriptions for resale, paying for accepted orders rather than committing to a fixed volume upfront, with no minimum purchase quantities or compulsory inventory commitments and the value of future sales yet to be established.
dorsaVi plans to support the rollout with partner training and commercial assistance while maintaining its own sales relationships in Australia and the US.
The French launch will sit alongside those established operations, rather than replace the sales activities dorsaVi already maintains in its two core markets.
Get the wire before the market opens.
The ASX small-cap stories that matter, filed before 9am AEST. Curated by the Small Caps desk.
